Razan Mansour

1.2k total citations
37 papers, 281 citations indexed

About

Razan Mansour is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Razan Mansour has authored 37 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Razan Mansour's work include Cancer Risks and Factors (6 papers), Global Cancer Incidence and Screening (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Razan Mansour is often cited by papers focused on Cancer Risks and Factors (6 papers), Global Cancer Incidence and Screening (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Razan Mansour collaborates with scholars based in Jordan, United States and Canada. Razan Mansour's co-authors include Maysa Al‐Hussaini, Hikmat Abdel‐Razeq, Asem Mansour, Reem A. Mustafa, Justin Z. Amarin, Akram Al‐Ibraheem, Omar Shamieh, Sverre Sandberg, Penelope E. Stein and Yonatan Edel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Razan Mansour

33 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Razan Mansour Jordan 11 90 54 47 41 33 37 281
W. Mulder Netherlands 13 95 1.1× 68 1.3× 31 0.7× 44 1.1× 15 0.5× 23 451
Ila M. Saunders United States 12 112 1.2× 30 0.6× 75 1.6× 38 0.9× 21 0.6× 47 360
Julia Fehniger United States 11 134 1.5× 31 0.6× 47 1.0× 32 0.8× 29 0.9× 25 397
The Lancet Oncology 7 227 2.5× 33 0.6× 36 0.8× 28 0.7× 44 1.3× 30 312
Abdullah A. Alsharm Saudi Arabia 6 209 2.3× 31 0.6× 30 0.6× 33 0.8× 41 1.2× 18 307
Sailaja Kamaraju United States 10 133 1.5× 17 0.3× 37 0.8× 61 1.5× 31 0.9× 50 320
Abhijit Pal Australia 12 73 0.8× 14 0.3× 63 1.3× 46 1.1× 30 0.9× 42 311
Elizabeth Stenger United States 11 31 0.3× 36 0.7× 57 1.2× 48 1.2× 47 1.4× 37 470
Deepa Maheswari Narasimhulu United States 12 70 0.8× 13 0.2× 44 0.9× 19 0.5× 42 1.3× 38 442
Liisa Lyon United States 17 137 1.5× 15 0.3× 88 1.9× 75 1.8× 47 1.4× 43 606

Countries citing papers authored by Razan Mansour

Since Specialization
Citations

This map shows the geographic impact of Razan Mansour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Razan Mansour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Razan Mansour more than expected).

Fields of papers citing papers by Razan Mansour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Razan Mansour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Razan Mansour. The network helps show where Razan Mansour may publish in the future.

Co-authorship network of co-authors of Razan Mansour

This figure shows the co-authorship network connecting the top 25 collaborators of Razan Mansour. A scholar is included among the top collaborators of Razan Mansour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Razan Mansour. Razan Mansour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mansour, Razan, Nausheen Ahmed, Muhammad Umair Mushtaq, et al.. (2025). Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Real-World Experience. Clinical Lymphoma Myeloma & Leukemia. 26(2). 94–105.
2.
Mansour, Razan, Abdallah Al‐Ani, Maysa Al‐Hussaini, et al.. (2024). Modifiable risk factors for cancer in the middle East and North Africa: a scoping review. BMC Public Health. 24(1). 223–223. 18 indexed citations
3.
Dima, Danai, Razan Mansour, James A. Davis, et al.. (2024). Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma. European Journal Of Haematology. 112(6). 975–983. 2 indexed citations
4.
Jarab, Anan S., Razan Mansour, Suhaib Muflih, et al.. (2024). Determinants of Health-Related Quality of Life in Outpatients with Myocardial Infarction. Journal of Multidisciplinary Healthcare. Volume 17. 2133–2145. 1 indexed citations
5.
Mansour, Razan, Hikmat Abdel‐Razeq, Maysa Al‐Hussaini, et al.. (2024). Systemic Barriers to Optimal Cancer Care in Resource-Limited Countries: Jordanian Healthcare as an Example. Cancers. 16(6). 1117–1117. 14 indexed citations
6.
Mansour, Razan, Hamza Hashmi, Aimaz Afrough, et al.. (2023). Efficacy of Daratumumab-Based Regimens in Anti-CD38 Treatment-Naïve Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics. Blood. 142(Supplement 1). 1985–1985.
7.
Farooq, Umer, Abdallah El Alayli, Abhiram Duvvuri, et al.. (2023). Nonsteroidal Anti-inflammatory Drugs for Chemoprevention in Patients With Familial Adenomatous Polyposis: A Systematic Review and Meta-Analysis. SHILAP Revista de lepidopterología. 2(7). 1005–1013. 3 indexed citations
8.
Hayden, Mary K., Kimberly E. Hanson, Janet A. Englund, et al.. (2023). The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing (December 2023). Clinical Infectious Diseases. 78(7). e385–e415. 6 indexed citations
9.
Mansour, Razan, Justin Z. Amarin, Abdallah Al‐Ani, Maysa Al‐Hussaini, & Asem Mansour. (2022). Palestinian Patients with Cancer at King Hussein Cancer Center. Frontiers in Oncology. 12. 997492–997492. 3 indexed citations
10.
Amarin, Justin Z., Razan Mansour, Omar Nimri, & Maysa Al‐Hussaini. (2021). Incidence of Cancer in Adolescents and Young Adults in Jordan, 2000-2017. JCO Global Oncology. 7(7). 934–946. 5 indexed citations
11.
Sultan, Iyad, et al.. (2021). Sex Differences in Cancer-Specific Survival Are Pronounced during Adolescence and Young Adulthood: A SEER Population-Based Study. SHILAP Revista de lepidopterología. 2(3). 391–401. 3 indexed citations
12.
Amarin, Justin Z., et al.. (2021). Glioblastoma in adolescents and young adults: An age-based comparative study from Jordan over a 17-year period. Cancer Epidemiology. 73. 101948–101948. 6 indexed citations
13.
Amarin, Justin Z., et al.. (2021). Differential Characteristics and Prognosis of PD-L1–Positive Endometrial Carcinomas: A Retrospective Chart Review. Life. 11(10). 1047–1047. 9 indexed citations
14.
Mansour, Razan, et al.. (2021). The clinical potential of circulating immune cell counts in primary gastric lymphoma. Journal of Gastrointestinal Oncology. 12(2). 365–376. 2 indexed citations
15.
Mansour, Razan, et al.. (2021). The Fair Allocation of Scarce Medical Resources: A Comparative Study From Jordan. Frontiers in Medicine. 7. 603406–603406. 11 indexed citations
16.
Mansour, Razan, et al.. (2020). Frequency of mismatch repair protein deficiency and PD-L1 in high-grade gliomas in adolescents and young adults (AYA). Brain Tumor Pathology. 38(1). 14–22. 5 indexed citations
17.
Mansour, Razan, et al.. (2020). <p>Hematological Indices of Distant Metastases and Prognostic Nomogram in Gastro-Pancreatic and Biliary Tract Cancers</p>. Cancer Management and Research. Volume 12. 9775–9786. 2 indexed citations
18.
Mansour, Razan, et al.. (2020). Disclosure of medical errors: physicians’ knowledge, attitudes and practices (KAP) in an oncology center. BMC Medical Ethics. 21(1). 74–74. 10 indexed citations
19.
Hamdan, Omar, et al.. (2020). The clinical value of peripheral immune cell counts in pancreatic cancer. PLoS ONE. 15(6). e0232043–e0232043. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Mulder Breakdown of academic impact, for papers by Ila M. Saunders Breakdown of academic impact, for papers by Julia Fehniger Breakdown of academic impact, for papers by The Lancet Oncology Breakdown of academic impact, for papers by Abdullah A. Alsharm Breakdown of academic impact, for papers by Sailaja Kamaraju Breakdown of academic impact, for papers by Abhijit Pal Breakdown of academic impact, for papers by Elizabeth Stenger Breakdown of academic impact, for papers by Deepa Maheswari Narasimhulu Breakdown of academic impact, for papers by Liisa Lyon
Rankless by CCL
2026